State Of Alaska, Department Of Revenue Halozyme Therapeutics, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 61,818 shares of HALO stock, worth $3.63 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
61,818
Previous 46,903
31.8%
Holding current value
$3.63 Million
Previous $2.99 Million
7.46%
% of portfolio
0.03%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding HALO
# of Institutions
587Shares Held
123MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$754 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$356 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$229 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$216 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.19B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...